Iranian Journal of Neonatology

Iranian Journal of Neonatology

Comparison of the Efficacy and Complications of Oral versus Intravenous Ibuprofen in Low-birth-weight Neonates with Patent Ductus Arteriosus: A Retrospective Cohort Study

Document Type : Original Article

Authors
Yazdan Ghandi 1
Masoud Bahrami 2
Afsaneh Akhondzadeh 2
Saeed Alinejad 2
1 Department of Pediatrics, Pediatric Cardiology, Arak University of Medical Sciences, Arak, Iran
2 Clinical Research Development Center of Amirkabir Hospital, Arak University of Medical Sciences, Arak, Iran
10.22038/ijn.2022.67909.2316
Abstract
Background: Patent ductus arteriosus (PDA) is associated with morbidity in preterm neonates. This study aimed to compare the efficacy of oral versus intravenous Ibuprofen in preterm neonates with PDA. 
Methods: 80 low birth weight neonates (gestational age
Keywords
Echocardiography
Ibuprofen
Neonate
Patent ductus arteriosus
  1. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews. 2020(1).
  2. Ghaderian M, Armanian AM, Sabri MR, Montaseri M. Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2019;24.
  3. Clyman RI, Couto J, Murphy GM, editors. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Seminars in Perinatology; 2012: Elsevier.
  4. Rolland A, Shankar-Aguilera S, Diomandé D, Zupan-Simunek V, Boileau P. Natural evolution of patent ductus arteriosus in the extremely preterm infant. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2015;100(1):F55-F8.
  5. Demirel G, Erdeve O, Dilmen U. Pharmacological management of PDA: oral versus intravenous medications. Current Clinical Pharmacology. 2012;7(4):263-70.
  6. Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomized controlled trial in extremely low birthweight infants. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2012;97(4):F279-F83.
  7. Zecca E, Romagnoli C, De Carolis MP, Costa S, Marra R, De Luca D. Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics. 2009;124(2):480-4.
  8. Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. The Journal of Clinical Pharmacology. 2003;43(9):968-73.
  9. Ghanem S, Mostafa M, Shafee M. Effect of oral ibuprofen on patent ductus arteriosus in premature newborns. Journal of the Saudi Heart Association. 2010;22(1):7-12.
  10. Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bijari BB, Noroozi E, et al. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iranian Journal of Pediatrics. 2016;26(4).
  11. Kumar A, Sundaram V, Yadav R, Oleti TP, Murki S, Krishna A, et al. Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (< 32 weeks): a blinded, randomised, active-controlled, non-inferiority trial. BMJ paediatrics open. 2017;1(1).
  12. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews. 2018(9).
  13. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo dang dai er ke za zhi= Chinese journal of contemporary pediatrics. 2007;9(5):399-403.
  14. Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara MB, Guellouze N, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics. 2008;
    122(6):e1256-e61.
  15. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral Ibuprofen and ductus arteriosus in premature infants: a randomized
    pilot study. American Journal of Perinatology. 2007;24(05):267-70.
  16. Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, et al. Association
    of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Jama. 2018;319(12):1221-38.
  17. Fesharaki HJ, Nayeri FS, Asbaq PA, Amini E, Sedaqat M. Different doses of ibuprofen in the treatment of patent ductus arteriosus: a randomized clinical trial. Tehran University Medical Journal. 2012;70(8).
  18. Narayanan-Sankar M, Clyman RI. Pharmacology review: pharmacologic closure of patent ductus arteriosus in the neonate. NeoReviews. 2003;
    4(8):e215-e21.
  19. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. The Journal of Pediatrics. 2011;158(4):549-54. e1.
  20. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics. 2003;
    112(5):e354-e.
  21. de Klerk JC, van Paassen N, van Beynum IM, Flint RB, Reiss IK, Simons SH. Ibuprofen treatment after the first days of life in preterm neonates with patent ductus arteriosus. The Journal of Maternal-Fetal & Neonatal Medicine. 2021;34(15):2411-7.
  22. Lu J, Li J, Li Q, Li Z. Meta-analysis to assess efficacy and safety of high-dose ibuprofen compared with standard treatment of patent ductus arteriosus in premature infants. Iranian Journal of Pediatrics. 2017;27(4).
  23. Neumann R, Schulzke SM, Bührer C. Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology. 2012;102(1):9-15.
  24. Alsafadi T, Gabel H, Dowaikh A, Albaloushi M, Suwaydi A, Alzahrani A, et al. Outcome of conservative and pharmacological treatment of hemodynamically significant patent ductus arteriosus in preterm infants less than 34 weeks. Journal of Clinical Neonatology. 2022;11(1):19.
  25. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Journal of the Medical Association of Thailand= Chotmaihet thangphaet. 2002;85:S1252-8.
  26. Erdeve O, Sarici SU, Sari E, Gok F. Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatric Nephrology. 2008;23(9):1565-7.
  27. Tiker F, Yildirim SV. Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus. Indian Pediatrics. 2007;44(1):54.
  28. Benitz W. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept
    the null hypothesis? Journal of Perinatology. 2010;30(4):241-52.

 

Iranian Journal of Neonatology
Volume 13, Issue 4
Autumn 2022
Pages 3-10